Business Description
OncoSec Medical Inc
NAICS : 325413
SIC : 2836
ISIN : US68234L4059
Compare
Compare
Traded in other countries / regions
ONCSQ.USA0KC7.UK IPO Date
2018-01-25Description
OncoSec Medical Inc. is a clinical-stage biotechnology company based in the United States that develops immunotherapies for cancer. Its lead program, ImmunoPulse IL-12, combines a plasmid encoding the proinflammatory cytokine interleukin-12 with in vivo electroporation to deliver the therapy directly into tumors and stimulate an anti-tumor immune response. The company has studied this approach in indications including metastatic melanoma, triple-negative breast cancer, and other solid tumors, often in combination with checkpoint inhibitors. OncoSec has no approved products and generates no product revenue, funding its research and clinical development through equity financings, partnerships, and collaborations. The company trades over the counter under the ticker ONMA and has faced financial and operational difficulties, including restructuring and going-concern uncertainty.
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OncoSec Medical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -15.238 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -51.09 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 143 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 143 - 143 | ||
| Shares Outstanding (Mil) | 5.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OncoSec Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OncoSec Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings results for 2027 | 2026-12-15 | In 84 days | ||
| Annual report for 2026 | 2026-10-19 | In 27 days | ||
| General meeting for 2025 | 2026-09-15 | -- | ||
| Third quarter earnings results for 2026 | 2026-09-15 | -- | ||
| Third quarter earnings results for 2026 | 2026-06-15 | -- | ||
| General meeting for 2025 | 2026-05-04 | -- | ||
| Second quarter earnings results for 2026 | 2026-05-04 | -- | ||
| First quarter earnings results for 2026 | 2026-04-13 | -- | ||
| 0.0454545:1 Stock Split | 2022-11-09 | -- | ||
| 0.1:1 Stock Split | 2019-05-21 | -- |
Show
Entries
OncoSec Medical Inc Frequently Asked Questions
What is OncoSec Medical Inc(LTS:0KC7)'s stock price today?
The current price of LTS:0KC7 is $143.00. The 52 week high of LTS:0KC7 is $143.00 and 52 week low is $143.00.
When is next earnings date of OncoSec Medical Inc(LTS:0KC7)?
The next earnings date of OncoSec Medical Inc(LTS:0KC7) is 2026-12-15 Est..
Does OncoSec Medical Inc(LTS:0KC7) pay dividends? If so, how much?
OncoSec Medical Inc(LTS:0KC7) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers